Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Editorial note

Expression of concern: Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey

Author: Philippa K Harris

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Excerpt

Following publication of this article (Daw and El-Bouzedi, BMC Infectious Diseases 2014, 14:17) [1] it has been brought to the Editors’ attention that much of this data appears to have been previously published in the following article [2]. In addition concerns about the authors’ right to use this data have been raised. Despite extensive efforts to obtain an independent investigation, we have been unable to secure advice on the matter. Given the uncertainty, the Editors advise the readers to interpret the data with due caution. We apologize to all affected parties. …
Literature
1.
Daw MA, El-Bouzedi A. Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey. BMC Infect Dis. 2014;14:17.CrossRefPubMedPubMedCentral
2.
Elzouki NA, Smeo MN, Sammud M, Elahmer O, Daw M, Furarah A, et al. Prevalence of hepatitis B and C virus infections and their related risk factors in Libya: a national seroepidemiological survey. East Mediterr Health J. 2013;19(7):589–99.PubMed
Metadata
Title
Expression of concern: Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey
Author
Philippa K Harris
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0772-8

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue

Research article

Non-tuberculous mycobacteria (NTM) in Zambia: prevalence, clinical, radiological and microbiological characteristics

Research article

Identification of clinical factors associated with severe dengue among Thai adults: a prospective study

Research article

Hemoptysis due to fungus ball after tuberculosis: A series of 21 cases treated with hemostatic radiotherapy

Research article

Surveillance of healthcare-associated infections in a neonatal intensive care unit in Italy during 2006–2010

Research article

Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV-burden setting

Research article

The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits